Presbyopia News

CHICAGO — In this Healio Video Perspective from the AAO meeting, AnnMarie Hipsley, DPT, PhD, founder and CEO of Ace Vision Group, discusses the benefits of laser scleral microporation, or LSM.

Tenpoint Therapeutics and Visus Therapeutics announced the completion of their merger, according to a press release.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Paul Smith of Orasis Pharmaceuticals announces the closing of a $78 million financing round that will help the company move toward the launch of Qlosi for presbyopia.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Daniel H. Chang, MD, of Empire Eye and Laser Center discusses his Refractive Surgery Subspecialty Day presentation on the categories of presbyopia-correcting IOLs.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Jennifer M. Loh, MD, shares results from the NEAR phase 3 clinical trials, which investigated Qlosi, a low-dose pilocarpine eye drop for the treatment of presbyopia.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Robert E. Ang, MD, presents 1-year study results of Supracor LASIK for presbyopia with two ablation profiles.

Ocuphire Pharma has dosed the first participants in the VEGA-3 phase 3 clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia, according to a press release.

In previous posts, I discussed the great potential for the use of AI-enabled technology for ophthalmology practice marketing, particularly in the area of marketing content production.